Nuclear Medicine Technology: Procedures And Quick Reference.epub

0 views

Skip to first unread message

Vaniria Setser

unread,

Jun 28, 2024, 12:52:47 PM6/28/24

to wechstumalcock

Journal of Nuclear Medicine Technology (JNMT) publishes material of interest to practitioners and scientists in the ﬁelds of nuclear medicine and molecular imaging. Proffered articles describing original laboratory or clinical investigations, brief communications, and letters to the editor will be considered for publication. Occasionally, invited articles, editorials, and invited perspectives of selected topics will be published. Manuscripts, including ﬁgures and tables, must be original and not under consideration by another publication.

In preparing manuscripts, authors should follow the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals ( ) of the International Committee of Medical Journal Editors and the speciﬁc instructions detailed below. Also, helpful guidance in conforming to the Recommendations may be found in Medical Style & Format: An International Manual for Authors, Editors, and Publishers (Philadelphia, PA: Lippincott Williams & Wilkins; 1989) and in the AMA Manual of Style (available by subscription at ).

Nuclear Medicine Technology: Procedures And Quick Reference.epub

Download File ❤ https://urllie.com/2yLfeC

Each author must have contributed signiﬁcantly to the submitted work. As recommended by the International Committee of Medical Journal Editors, all authors must have made substantial contributions in all 3 of the following categories:

Simple participation or collection of data alone does not justify authorship but should be mentioned in the acknowledgment section. Changes in authorship after the ﬁrst review require a written request by the corresponding author and a written authorization from the authors who are to be added or deleted.

For human studies, approval must be obtained from the institutional review board or equivalent ethics committee and written informed consent must be obtained from research subjects, unless this requirement is waived by the institutional review board or equivalent. For studies in the United States, compliance with the Health Insurance Portability and Accountability Act is also required. Authors must also comply with the clinical trial registration statement from the International Committee of Medical Journal Editors, and the clinical trial registration number must be provided.

For animal studies, approval must be obtained from the appropriate institutional animal care and use committee for compliance with the National Institutes of Health for use of laboratory animals or equivalent.

All manuscripts submitted to Journal of Nuclear Medicine Technology should be accompanied by a copyright disclosure statement in compliance with the Copyright Revision Act of 1976, effective January 1, 1978. The Assignment of Copyright agreement must be included as a supplemental file in your submission or sent by email to the JNMT ofﬁce (jn...@snmmi.org). For the JNMT Assignment of Copyright form, click here.

Manuscripts presenting research that was funded in whole or part by US/UK/EU government organizations, such as NIH (US) and Wellcome Trust (UK), are welcomed by JNMT. Upon ﬁnal publication, these manuscripts will be deposited to PubMed Central with an embargo period of 6 months. If Immediate Open Access (IOA) is selected, the embargo is waived. Refer to section below for details on IOA.

Submitted manuscripts are reviewed for originality, signiﬁcance, adequacy of documentation, composition, and adherence to these guidelines. However, editorial decisions are based not only on the technical merits of the work but also on factors such as priority for publication and relevance to the general readership of JNMT. All manuscripts are judged in relation to other submissions currently under consideration.

Manuscripts must be written in English. When necessary, authors should seek the assistance of experienced, English-speaking medical editors before submission. A medical editor should review the ﬁnal draft of the original and any revisions of the manuscript. Authors will be required to provide revisions of articles written in substandard English before peer review.

Manuscripts considered suitable for review are evaluated by two reviewers. The Editors select the reviewers and make the ﬁnal decision on the manuscript. Authors may suggest reviewers for their manuscripts. Referees who review a manuscript remain unknown to the authors.

It is unusual for a manuscript to be accepted for publication without ﬁrst undergoing a process of revision. Revised manuscripts are judged on the adequacy of responses to suggestions and criticisms made during the initial review. Revision of a manuscript does not guarantee acceptance.

In the revised manuscript, red text should be used to indicate all changed text within the manuscript itself. Significant deletions should be noted in the point-by-point reply only. A clean version of the manuscript should also be provided. Markup from the tracked changes feature in Microsoft Word are not supported by submission system and will not appear on the review PDF. The revised manuscript can be supplied as a PDF as long as its original file is supplied in Microsoft Word format as a supplemental file.

The revised manuscript, accompanying reply, and all files to be published must be submitted to JNMT via the online submission system ( -jnm.snmjournals.org) within 30 days of the date of the editorial decision. If circumstances prevent completing the revisions by the deadline, please contact Susan Alexander at 703-326-1185 or at sale...@snmmi.org. If the revisions are not received within 3 months after being requested, the manuscript may be started on a new review cycle and given a new manuscript number.

Consideration for publication of manuscripts deposited to a preprint server will involve determining if publication of the submitted manuscript will add meaningful new information to the medical literature. Final determinations are at the discretion of the journal Editor.

Original scientiﬁc and methodology articles should contain no more than 6,000 words. This word limit includes all data: title page, abstract, text, disclosure, acknowledgments, key points, references, ﬁgure legends, and tables. The goal is to limit original articles to 8 printed pages. A maximum of 7 ﬁgures (maximum of 14 parts in total with no more than 4 parts per ﬁgure preferred), 7 tables, and 40 references is allowed. Abstracts should be structured and should contain a maximum of 350 words.

Brief Communications should present novel and broadly important data, syntheses, or concepts. They should contain no more than 2,500 words; this word limit includes all data: title page, abstract, text, disclosure, acknowledgments, key points, references, tables, and ﬁgure legends. The goal is to limit brief communications to 5 printed pages in the journal. A maximum of 4 ﬁgures, 2 tables, and 20 references is allowed. Abstracts should be structured and should contain a maximum of 150 words.

Use a type size of at least 10 points, double spacing every line. Use the following order for the sections of the manuscript: title page; abstract; text; ﬁnancial disclosure; disclaimer, if any; acknowledgments, if any; references; ﬁgures with legends; and tables. Number all pages consecutively. Do not use automated word-processing features or embedding for numbering, footnotes, or endnotes.

A structured abstract must be included with each original scientiﬁc manuscript, including brief communications. The abstract should contain a maximum of 350 words for original scientiﬁc and methodology articles or 150 words for brief communications and include 4 clearly identiﬁable elements of content: rationale (goals of the investigation), methods (description of study subjects, experiments, and observational and analytic techniques), results (major ﬁndings), and principal conclusions. Except for the rationale, these sections should be preceded by headings (i.e., Methods, Results, and Conclusion). Three to 5 key words should also be submitted with the abstract.

Describe procedures in sufﬁcient detail to allow other investigators to reproduce the results. Do not use hyperbolic terms or phrases in the title, abstract, or body of the text. Qualitative claims as to the superiority (superior, best) or primacy (ﬁrst, novel, unique) of an idea or instrument are not acceptable. Do not use numbered or bulleted lists. Any brand-name or trademarked instrument, pharmaceutical, or other product mentioned must be followed by the name of the manufacturer, in parentheses. The use of generic names is preferred to the use of brand names or trademarked names. Original scientiﬁc and methodology articles are divided into the following sections:

This section should summarize any advances in knowledge provided by the results and then discuss their implications in relation to other studies. Limitations and biases of the study must be addressed. The direction of future research may be mentioned.

References (not to exceed 60 in an original scientiﬁc or methodology article, 30 in a brief communication, or 10 in a letter) should be cited in consecutive numeric order at ﬁrst mention in the text and designated by reference number italicized, in red font, and in parentheses. References appearing only in a table or ﬁgure should be placed at the end of the reference list.

All measurements should be listed in Systme Internationale (SI) units. Non-SI units may be used after the SI units but should be placed in parentheses. Use becquerels, not curies, as the unit of activity (1 mCi = 37 MBq).

With the exception of units of measurement, JNMT strongly discourages the use of abbreviations. Whenever possible, terms should be spelled out in full rather than being abbreviated. Every abbreviation, even those that are well known and in common use, must be deﬁned the ﬁrst time it is mentioned in the manuscript; spell out the full term and place the abbreviation, in parentheses, after the full term.

JNMT endorses the application of the International Consensus Radiochemistry Nomenclature Guidelines for contributions to the journal. We strongly recommend all manuscripts meet these submission guidelines, and all reviewers check that the guidelines are followed.